In this issue
-
Without effective antibiotics, accelerated action on NCDs is at risk
A coordinated response to antimicrobial resistance (AMR) and noncommunicable diseases (NCDs) is essential to building healthier populations worldwide, and pull incentives for antibiotics are part of the solution. AMR and NCDs represent two of the greatest threats to global health and development that we face. Coordinated political leadership at the United Nations, across G7 countries,...
-
s Sponsored
The five steps for a stronger African One Health response to AMR
No single sector can solve Africa’s antimicrobial resistance (AMR) challenge on its own. Only a One Health response — uniting human, animal and environmental health — can curb AMR and protect communities. All 47 WHO African Region countries have AMR National Action Plans framed around One Health. Yet, coordination between human, animal, agriculture and environmental...
-
s Sponsored
African coordination can turn the tide on AMR
Antimicrobial resistance (AMR) demands a coordinated African continental response. It’s time to accelerate national plans and regional action in Africa. Africa has the highest AMR mortality rates globally.1 One in five bacterial infections in Africa is now resistant.2 By 2050, Africa is projected to bear 40% of global AMR-related deaths.3 Without intervention, 4 million people...
-
s Sponsored
Putting prevention at the heart of AMR strategies
Infection prevention is not a side strategy; it is the foundation of an effective AMR response. We need a holistic approach which goes beyond routine vaccination, hygiene and sanitation measures. Antimicrobial resistance (AMR) could affect anyone, at any stage of life. It also has a significant economic impact. AMR costs EU countries around €12 billion1 ...
-
s Sponsored
Phage therapy and the future of global antimicrobial resistance
As antibiotic resistance increases, Armata Pharmaceuticals CEO Dr Deborah Birx shares how Armata is reimagining how we treat bacterial infections, pioneering novel phage therapy for greater clinical impact with minimal harm. Antimicrobial resistance (AMR) is rapidly becoming one of the greatest challenges faced by modern medicine, threatening to render current antibiotic treatments of bacterial infections...
-
Invisible frontlines: tackling antimicrobial resistance amid conflict and fragility
Antimicrobial resistance (AMR) is a major global health threat. In fragile and conflict-affected settings, this risk is magnified, and the consequences are often invisible. In most conflict zones, health systems become fractured with weak governance, damaged infrastructure, workforce depletion and disrupted supply chains. Policies meant for functional health systems may not work in fragile settings....
-
Responsible practices that can help safeguard our food systems
Applying proven best practices across farms and food systems is key to preserving the effectiveness of antimicrobials. Antimicrobial resistance (AMR) threatens the effectiveness of medicines essential for people and animals. In agrifood systems, antimicrobials can treat and control disease in livestock, aquaculture and plants. When these substances are misused, resistant microorganisms can develop and spread...
-
s Sponsored
Patents power innovation against antimicrobial resistance
Discover how patent protection drives innovation in fighting antimicrobial resistance (AMR), encouraging collaboration, research investment and global access to life-saving interventions. The rapid emergence and spread of antimicrobial resistance pose significant challenges to global health, threatening the effectiveness of existing antibiotics and other antimicrobial agents. Addressing this crisis requires considered innovation in the development of...
-
Dengue awareness: a critical front in the fight against AMR and infectious diseases
Dengue is more than a mosquito-borne disease; it drives unnecessary antibiotic use and fuels antimicrobial resistance. Preventing dengue is a critical step in protecting lives, health systems and the future effectiveness of life-saving medicines. Dengue prevention is AMR prevention — every life saved today protects the medicines we all need tomorrow. Link between AMR and...
-
Finding the missing millions: how next-gen diagnostics can transform TB response
Each year, nearly 3 million people with tuberculosis (TB) are ‘missed’ by health systems – undiagnosed or unreported – allowing the world’s deadliest infectious disease to persist.1 Today’s diagnostics are accurate but too scarce, costly or unsuitable for those at most risk. Some go untreated; others receive the wrong treatment; and drug-resistant strains spread –...
Global Cause